1. ALLA AKTIER
  2. NYHETER
  3. SURGICAL SCIENCE SWEDEN

Surgical Science Sweden

Nyheter Surgical Science Sweden Nyheter alla bolag

Tom Englund takes over as the new CEO of Surgical Science

In July, it was announced that Tom Englund will take over as the new CEO of Surgical Science on October 1, 2024. Tom starts his new position as of today and succeeds Gisli Hennermark, who remains in an advisory role until the end of March 2025. Gisli also continues as a member of the Board of Surgical Science. Before his appointment, Tom has bought 2,430 shares in Surgical Science.

Gothenburg, Sweden, October 1, 2024
Surgical Science Sweden AB (publ)

This press release, in its entirety, is available through the attachment or via:
https://surgicalscience.com/investor-relations/#press-releases

See also press release from July 1, 2024, "Tom Englund appointed new CEO of Surgical Science"

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

For further information, please contact:

Tom Englund, CEO
Telephone: +46-70-916 16 81
E-mail: tom.englund@surgicalscience.com

Anna Ahlberg, CFO
Telephone: +46-70-855 38 35
E-mail: anna.ahlberg@surgicalscience.com

About Surgical Science Sweden AB (publ)

One of the biggest challenges within healthcare globally is reducing injuries incurred during care. Medical education and training are key, especially as a large part of the training can now be performed outside the operating room. Surgical Science is a world leader in the development of virtual reality simulators for evidence-based training. The simulators enable surgeons and other medical specialists to train and improve their psycho-motor skills and instrument handling before entering the clinical environment. Alongside its own products, Surgical Science works with simulation solutions for medical device companies that develop instruments for clinical use, such as robotic surgery.

Surgical Science has approximately 260 employees. The company is headquartered in Gothenburg, Sweden and also has operations in Tel Aviv, Israel, as well as in Stockholm, Sweden and in Seattle and Cleveland, US. Through sales offices in the US and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Shares in Surgical Science Sweden AB (publ) are traded on Nasdaq First North Growth Market. Certified Adviser is Carnegie Investment Bank AB (publ).

Attachments

Tom Englund takes over as the new CEO of Surgical Science

Datum 2024-10-01, kl 08:30
Källa MFN
Bifogade filer
Tom Englund takes over as the new CEO of Surgical Science
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!